Logo-jnp
J Nephropathol. 2020;9(3): e25.
doi: 10.34172/jnp.2020.25

Scopus ID: 85084673454
  Abstract View: 4027
  PDF Download: 993

Original Article

Comparison of the effects of pramipexole and gabapentin on the treatment of restless leg syndrome in end-stage chronic renal failure patients undergoing hemodialysis

Sepideh Hajian 1* ORCID logo, Mohammad Reza Rajabpoor Nikfam 2, Zahra Esmayeilzad 2 ORCID logo

1 Department of Nephrology, Velayat Hospital, Qazvin University of Medical Sciences, Qazvin, Iran
2 Velayat Hospital, Qazvin University of Medical Sciences, Qazvin, Iran
*Corresponding Author: Email: sepideh.hajian2016@gmail.com

Abstract

Introduction: Despite the high prevalence of restless legs syndrome (RLS) in hemodialysis patients, few studies have investigated the effect of pramipexole and gabapentin on the severity of RLS in these patients.

Objectives: The study aimed to evaluate the effects of pramipexole and gabapentin on the treatment of RLS in end-stage chronic renal failure patients undergoing hemodialysis.

Patients and Methods: Using the diagnostic criteria the presence of RLS was investigated in all hemodialysis patients admitted to the dialysis ward of Bu Ali Sina and Velayat hospitals in Qazvin, Iran. Out of 162 patients, 96 patients had RLS and 60 patients with moderate to severe RLS were enrolled in the study. The selected patients were randomly divided into two groups including pramipexole (0.18 mg daily) and gabapentin (100 mg daily). The two groups were treated for 4 weeks.

Results: The prevalence of RLS was 59% (96 out of 162 patients). After the intervention, the severity of RLS was significantly decreased in all patients and also in each of the pramipexole and gabapentin groups (P<0.001). Moreover, after the intervention, the rate of improvement in RLS severity in the pramipexole group (16.8 ± 6.5) was significantly higher than that in the gabapentin group (13.0 ± 7.3; P=0.036).

Conclusion: The findings of the study showed that the severity of RLS in hemodialysis patients undergoing 4 weeks of treatment with pramipexole or gabapentin was significantly reduced; in addition, the rate of improvement in RLS severity was higher in pramipexole group.


Implication for health policy/practice/research/medical education:

In a clinical trial to study the effects of pramipexole and gabapentin on the treatment of RLS in end-stage chronic renal failure patients undergoing hemodialysis, we found the severity of RLS in hemodialysis patients undergoing four weeks of treatment with pramipexole or gabapentin was significantly reduced. In addition, the rate of improvement in RLS severity was higher in the pramipexole group.

Please cite this paper as: Hajian S, Rajabpoor Nikfam MR, Esmayeilzad Z. Comparison of the effects of pramipexole and gabapentin on the treatment of restless leg syndrome in end-stage chronic renal failure patients undergoing hemodialysis. J Nephropathol. 2020;9(3):e25. DOI: 10.34172/jnp.2020.25.

First Name
Last Name
Email Address
Comments
Security code


Abstract View: 4028

Your browser does not support the canvas element.


PDF Download: 993

Your browser does not support the canvas element.

Submitted: 19 Dec 2020
Accepted: 05 Feb 2020
ePublished: 12 Feb 2020
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)